Abstract
We review our experience on Rifaximin in uncomplicated diverticular disease. Our data show that a 2 week treatment induces modifications in the immune system: local mucosal lymphocytes with TLR-4 were increased. In the peripheral blood CD103 cells, which increased before treatment, returned to normal values after Rifaximin.
Lingua originale | English |
---|---|
pagine (da-a) | 218-221 |
Numero di pagine | 4 |
Rivista | MINI-REVIEWS IN MEDICINAL CHEMISTRY |
Volume | 16 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- diverticular disease